AMBALALSABSEAmbalal Sarabhai Enterprises LtdMediumNeutral
Announced Wed, 8 Jul · 16:20 IST

Revised Annual Report submitted for FY 2025-26 after errors noticed

Related Party TransactionsResults RestatedResults View source PDF

AMBALALSA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹31.97
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.0-0.9-1.5-2.9-2.3-3.6
Up moveDown movePending
AI summary

Company has submitted a Revised Annual Report for FY 2025-26 after noticing inadvertent errors in the original. Corrections have been carried out and the revised report is uploaded on the company website. Revisions do not affect the AGM date, time, venue, or business. The 48th AGM is scheduled for July 30, 2026 at 11:00 AM via video conferencing. AGM notice includes re-appointment of three key directors and approval of loans or guarantees up to Rs 10 crores each to related parties including Synbiotics, Asence Pharma, and Systronics India.

Likely market impact

Revised report is a minor governance red flag, but AGM schedule and business remain unchanged. Shareholders may want to review the corrections.